WallStSmart

Cresud SACIF y A (CRESY)vsGraham Holdings Co (GHC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Cresud SACIF y A generates 27115% more annual revenue ($1.38T vs $5.07B). CRESY leads profitability with a 12.9% profit margin vs 10.7%. CRESY trades at a lower P/E of 6.4x. GHC earns a higher WallStSmart Score of 68/100 (B-).

CRESY

Buy

50

out of 100

Grade: C-

Growth: 6.0Profit: 6.0Value: 6.7Quality: 4.5
Piotroski: 6/9Altman Z: 0.90

GHC

Strong Buy

68

out of 100

Grade: B-

Growth: 7.3Profit: 6.0Value: 4.7Quality: 8.0
Piotroski: 4/9Altman Z: 3.17
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CRESY.

GHCSignificantly Overvalued (-24.8%)

Margin of Safety

-24.8%

Fair Value

$888.62

Current Price

$1146.11

$257.49 premium

UndervaluedFair: $888.62Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CRESY3 strengths · Avg: 9.3/10
P/E RatioValuation
6.4x10/10

Attractively priced relative to earnings

Price/BookValuation
0.9x10/10

Reasonable price relative to book value

Free Cash FlowQuality
$4.88B8/10

Generating 4.9B in free cash flow

GHC5 strengths · Avg: 9.8/10
P/E RatioValuation
9.1x10/10

Attractively priced relative to earnings

Price/BookValuation
1.0x10/10

Reasonable price relative to book value

EPS GrowthGrowth
676.0%10/10

Earnings expanding 676.0% YoY

Altman Z-ScoreHealth
3.1710/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.289/10

Conservative balance sheet, low leverage

Areas to Watch

CRESY4 concerns · Avg: 2.5/10
Market CapQuality
$861.03M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.503/10

Elevated debt levels

EPS GrowthGrowth
-50.3%2/10

Earnings declined 50.3%

Altman Z-ScoreHealth
0.902/10

Distress zone — elevated risk

GHC2 concerns · Avg: 2.5/10
Return on EquityProfitability
6.3%3/10

ROE of 6.3% — below average capital efficiency

PEG RatioValuation
4.042/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : CRESY

The strongest argument for CRESY centers on P/E Ratio, Price/Book, Free Cash Flow.

Bull Case : GHC

The strongest argument for GHC centers on P/E Ratio, Price/Book, EPS Growth.

Bear Case : CRESY

The primary concerns for CRESY are Market Cap, Debt/Equity, EPS Growth. Debt-to-equity of 1.50 is elevated, increasing financial risk.

Bear Case : GHC

The primary concerns for GHC are Return on Equity, PEG Ratio.

Key Dynamics to Monitor

GHC carries more volatility with a beta of 0.71 — expect wider price swings.

CRESY is growing revenue faster at 8.3% — sustainability is the question.

CRESY generates stronger free cash flow (4.9B), providing more financial flexibility.

Monitor CONGLOMERATES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

GHC scores higher overall (68/100 vs 50/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cresud SACIF y A

INDUSTRIALS · CONGLOMERATES · USA

Cresud Sociedad Annima Comercial, Inmobiliaria, Financiera y Agropecuaria, an agricultural company, produces agricultural commodities in Brazil and other Latin American countries. The company is headquartered in Buenos Aires, Argentina.

Visit Website →

Graham Holdings Co

INDUSTRIALS · CONGLOMERATES · USA

Graham Holdings Company is a diversified global media and education company. The company is headquartered in Arlington, Virginia.

Visit Website →

Want to dig deeper into these stocks?